CROMOLYN SODIUM solution, concentrate USA - engelska - NLM (National Library of Medicine)

cromolyn sodium solution, concentrate

ailex pharmaceuticals, llc - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium oral solution (concentrate) is indicated in the management of patients with mastocytosis. use of this product has been associated with improvement in diarrhea, flushing, headaches, vomiting, urticaria, abdominal pain, nausea, and itching in some patients. cromolyn sodium oral solution (concentrate) is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium.

Negative-pressure wound therapy system dressing set Australien - engelska - Department of Health (Therapeutic Goods Administration)

negative-pressure wound therapy system dressing set

k care healthcare solutions pty ltd - 47956 - negative-pressure wound therapy system dressing set - carilex dressing kits is indicated for patients who benefit from wound management therapy via the application of negative pressure wound therapy for the removal of fluids and excess exudates, infectious material, and tissue debris which may promote wound healing.

SODIUM PHENYLACETATE AND SODIUM BENZOATE injection, solution, concentrate USA - engelska - NLM (National Library of Medicine)

sodium phenylacetate and sodium benzoate injection, solution, concentrate

ailex pharmaceuticals, llc - sodium phenylacetate (unii: 48n6u1781g) (phenylacetic acid - unii:er5i1w795a), sodium benzoate (unii: oj245fe5eu) (benzoic acid - unii:8skn0b0mim) - sodium phenylacetate 100 mg in 1 ml - sodium phenylacetate and sodium benzoate injection, 10%/10% is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. during acute hyperammonemic episodes, arginine supplementation, caloric supplementation, dietary protein restriction, hemodialysis, and other ammonia lowering therapies should be considered [see warnings and precautions (5) ]. none. pregnancy category c. animal reproduction studies have not been conducted with sodium phenylacetate and sodium benzoate injection, 10%/10%. it is not known whether sodium phenylacetate and sodium benzoate injection, 10%/10% can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. thus, sodium phenylacetate and sodium benzoate injection, 10%/10% should be given to a pregnant woman only if clearly needed. it is not known whether sodium phenylacetate, sodium benzoate, or their conjugation p

BISMUTH SUBSALICYLATE/METRONIDAZOLE/TETRACYCLINE HYDROCHLORIDE- bismuth subsalicylate chewable tablets/metronidazole tablets/tet USA - engelska - NLM (National Library of Medicine)

bismuth subsalicylate/metronidazole/tetracycline hydrochloride- bismuth subsalicylate chewable tablets/metronidazole tablets/tet

ailex pharmaceuticals, llc - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - the components of bismuth subsalicylate chewable tablets/ metronidazole tablets/tetracycline hydrochloride capsules (bismuth subsalicylate, metronidazole, and tetracycline hydrochloride), in combination with an h2 antagonist, are indicated for the eradication of h. pylori for treatment of patients with h. pylori infection and duodenal ulcer disease (active or a history of duodenal ulcer). the eradication of h. pylori has been demonstrated to reduce the risk of duodenal ulcer recurrence in patients with active duodenal ulcer disease (see clinical studies and dosage and administration ). to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptib

Pressure alleviation pad, air, alternating contact, control unit Australien - engelska - Department of Health (Therapeutic Goods Administration)

pressure alleviation pad, air, alternating contact, control unit

k care healthcare solutions pty ltd - 36688 - pressure alleviation pad, air, alternating contact, control unit - alternating air control unit that can be used with pressure relieving surfaces to provide provide pressure relief.

Pressure alleviation pad, <specify> Australien - engelska - Department of Health (Therapeutic Goods Administration)

pressure alleviation pad, <specify>

k care healthcare solutions pty ltd - 35225 - pressure alleviation pad, - this is a non powered mattress replacement which has been designed to offer pressure relief.

Alternating-pressure chair cushion, reusable Australien - engelska - Department of Health (Therapeutic Goods Administration)

alternating-pressure chair cushion, reusable

k care healthcare solutions pty ltd - 47123 - alternating-pressure chair cushion, reusable - an alternating pressure cushion system to assist in the treatment and prevention of pressure ulcers.

Cushion, foot Australien - engelska - Department of Health (Therapeutic Goods Administration)

cushion, foot

k care healthcare solutions pty ltd - 11095 - cushion, foot - heel protector - used to assist the treatment and prevention of pressure ulcers on the heel area.